1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Australian Oilseeds Holdings received a Nasdaq notice that its share price has been below the $1.00 minimum for 30 consecutive business days, with until November 24, 2025 to regain compliance. For the quarter ended March 31, 2025, sales revenue rose 49.8% to A$9.4 million, but the company swung to a net loss of A$0.6 million from net income of A$41 thousand a year earlier.
Nasdaq bid price notice received May 27, 2025; 180 calendar days, to November 24, 2025, to regain compliance with the $1.00 minimum
Sales revenue up 49.8% to A$9.4 million; retail oil revenue up 69.4% to A$4.7 million
Net loss of A$0.6 million versus net income of A$41 thousand in the prior-year quarter
Effective May 22, 2025, JSKS Enterprises, controlled by CEO Gary Seaton, converted about A$5 million of loans into 4,452,479 shares at $0.7241 per share
Abercrombie & Fitch reported first quarter net sales of $1.1 billion, up 8% from a year earlier, but diluted earnings per share fell to $1.59 from $2.14 and operating margin fell to 9.3% from 12.7%. The company lowered its full-year fiscal 2025 net income per diluted share outlook to $9.50 to $10.50 from $10.40 to $11.40, and cut its operating margin outlook to 12.5% to 13.5% from 14% to 15%.
Net sales of $1.1 billion, up 8%, with comparable sales up 4%; Hollister brands up 22% and Abercrombie brands down 4%
Diluted EPS of $1.59 versus $2.14 a year earlier; operating income of $102 million versus $130 million
Full-year fiscal 2025 EPS outlook lowered to $9.50 to $10.50 from $10.40 to $11.40; net sales growth outlook of 3% to 6% versus 3% to 5% previously
Repurchased 2.6 million shares for $200 million in the quarter, with $1.1 billion remaining on the authorization set in March 2025
Kohl's reported first-quarter fiscal 2025 results for the quarter ended May 3, 2025, with net sales down 4.1% and a net loss of $15 million, compared with $27 million a year earlier. The company affirmed its full-year 2025 outlook, while the presentation says the Board reduced the annual dividend to $0.50 per share and Michael Bender is serving as Interim CEO.
Net sales decreased 4.1% to $3.0 billion; comparable sales fell 3.9%.
Net loss was $15 million, or ($0.13) per diluted share, versus $27 million, or ($0.24) per share, a year earlier.
Full-year 2025 guidance was affirmed, including diluted EPS of $0.10 to $0.60.
Quarterly dividend of $0.125 per share is payable June 25, 2025, to holders of record on June 11, 2025.
Hormel Foods reported second-quarter fiscal 2025 results for the quarter ended April 27, 2025, with net sales of $2.90 billion, up 0.4% from a year earlier, while diluted earnings per share were $0.33 compared with $0.34. The company narrowed its fiscal 2025 outlook, lowering the top of its diluted EPS range to $1.59 from $1.63 and raising the bottom of its net sales range to $12.0 billion from $11.9 billion, so shareholders face a narrower profit expectation with a lower ceiling.
Net sales of $2.90 billion, up 0.4%; organic net sales up 1%
Operating income of $248 million vs. $252 million a year earlier; adjusted operating income of $265 million vs. $276 million
Diluted EPS of $0.33 vs. $0.34; adjusted diluted EPS of $0.35 vs. $0.38
Fiscal 2025 diluted EPS range narrowed to $1.49 to $1.59 from $1.49 to $1.63; net sales range set at $12.0 to $12.2 billion from $11.9 to $12.2 billion
HP reported fiscal 2025 second-quarter net revenue of $13.2 billion, up 3.3% from a year earlier, while GAAP diluted EPS fell 31% to $0.42 and non-GAAP diluted EPS fell 13% to $0.71, below its previously provided outlook. CFO Karen Parkhill said the company adjusted its outlook for moderated demand and trade-related costs, and it now expects non-GAAP diluted EPS of $3.00 to $3.30 for fiscal 2025.
Q2 net revenue $13.2 billion, up 3.3%; GAAP diluted EPS $0.42, down from $0.61; non-GAAP diluted EPS $0.71, down from $0.82
Non-GAAP diluted EPS was below the previously provided outlook of $0.75 to $0.85; GAAP EPS was below $0.62 to $0.72
Q3 fiscal 2025 non-GAAP diluted EPS estimated at $0.68 to $0.80; full-year non-GAAP diluted EPS $3.00 to $3.30 and free cash flow $2.6 to $3.0 billion
Q2 free cash flow was $(95) million; $100 million spent on share repurchases and $273 million on dividends
On May 28, 2025, e.l.f. Beauty agreed to buy rhode, the skin care and makeup brand founded by Hailey Bieber, for $800 million at closing plus up to $200 million in earnout payments. The cash portion is backed by $600 million of committed debt financing, and the stock portion adds new e.l.f. shares, so the deal changes the company's debt and share count if it closes. The same day, the company reported fiscal 2025 results: fourth-quarter net sales rose 4%, but full-year GAAP diluted earnings per share fell to $1.92 from $2.21, and the company gave no fiscal 2026 outlook.
Closing consideration is $800 million: $600 million in cash and about $200 million in Company stock, valued at $77.1685 per share, subject to adjustments.
Earnout of up to $200 million in cash over three years: up to $100 million tied to revenue projections and up to $100 million more on overachievement.
The transaction is expected to close in the quarter ending September 30, 2025; the agreement can be terminated if the merger is not consummated by September 25, 2025, and Buyer owes a $65 million reverse termination fee in certain circumsta
Fourth quarter net sales rose 4% to $332.6 million and GAAP diluted EPS was $0.49, versus $0.25; full-year net sales rose 28% to $1,313.5 million while full-year GAAP net income fell to $112.1 million from $127.7 million.
Vail Resorts' board appointed Executive Chairperson Rob Katz as CEO effective May 22, 2025, succeeding Kirsten Lynch, who also stepped down as a director. The company reaffirmed its fiscal 2025 guidance but now expects Resort Reported EBITDA in the lower half of the range issued March 10, 2025, excluding one-time CEO transition costs. Katz's CEO compensation has not yet been set and will be disclosed in a later amendment.
Katz became CEO effective May 22, 2025; Lynch's departure is treated as a termination without cause.
Fiscal 2025 Resort Reported EBITDA is expected in the lower half of the guidance range issued March 10, 2025, excluding one-time CEO transition costs.
Lynch will provide strategic advisory services through September 26, 2025, and her vested stock appreciation rights must be exercised within 90 days after that date.
Early season pass sales through the May 26, 2025 deadline are consistent with trends given in the April 24, 2025 metrics release.
StepStone Group reported fourth-quarter and full fiscal 2025 results for the period ended March 31, 2025, and declared a $0.24 quarterly dividend plus a $0.40 supplemental dividend. Revenue grew in both periods, but GAAP results weakened: the company posted a net loss attributable to StepStone of $179.6 million for the year, compared with net income of $58.1 million a year earlier. Adjusted net income per share rose, which the company highlights as a measure of core operating performance.
Full-year total revenues were $1.17 billion, up 65% from $711.6 million; full-year GAAP diluted loss per share was $2.52, versus $0.91 of income in fiscal 2024.
Fourth-quarter total revenues were $377.7 million, up from $356.8 million; net loss attributable to StepStone was $18.5 million, versus $30.8 million of net income a year earlier.
Fourth-quarter adjusted net income per share was $0.68, up from $0.33; fee-related earnings were $94.1 million, up from $50.9 million.
Dividends are payable June 30, 2025, to holders of record as of June 13, 2025.
Workday reported fiscal 2026 first-quarter revenue of $2.240 billion, up 12.6% year over year, while GAAP diluted earnings per share fell to $0.25 from $0.40 after $166 million in restructuring expenses. The company also reiterated its fiscal 2026 subscription revenue guidance of $8.8 billion, raised its non-GAAP operating margin guidance to approximately 28.5%, and authorized a new $1.0 billion share repurchase program.
Total revenues were $2.240 billion, up 12.6%; non-GAAP diluted EPS was $2.23 versus $1.74 a year earlier.
GAAP operating income was $39 million, down from $64 million, including $166 million of restructuring expenses.
Fiscal 2026 subscription revenue guidance of $8.8 billion was reiterated; non-GAAP operating margin guidance was raised to approximately 28.5%.
The Board authorized repurchases of up to $1.0 billion of Class A common stock with no expiration date.
Ross Stores reported first-quarter fiscal 2025 diluted earnings per share of $1.47, up from $1.46, on sales of $5.0 billion, though net income fell to $479 million from $488 million and comparable store sales were flat. The company withdrew its annual sales and earnings guidance, citing tariff and macroeconomic uncertainty, and projected second-quarter EPS of $1.40 to $1.55 versus $1.59 a year earlier. Shareholders no longer have a full-year outlook, and the company said it expects profitability pressure if tariffs stay at elevated levels.
Q1 diluted EPS $1.47 vs $1.46 a year earlier; net income $479 million vs $488 million; sales $5.0 billion; comparable store sales flat
Annual sales and earnings guidance withdrawn; outlook provided for the 13 weeks ending August 2, 2025 only
Q2 comparable store sales projected flat to up 3%; Q2 EPS projected $1.40 to $1.55, including a $0.11 to $0.16 per share tariff cost impact
Repurchased $263 million of stock in Q1 under a $2.1 billion authorization; still on track to buy back $1.05 billion in fiscal 2025
EnerSys reported fiscal fourth-quarter 2025 net sales of $974.8 million, up 7.0%, and GAAP diluted EPS of $2.41, up 63%. Adjusted EPS of $2.97 exceeded the company's $2.75 to $2.85 guidance range. The company paused full-year quantitative guidance, citing the evolving policy environment, and gave a first-quarter fiscal 2026 outlook with lower sales and EPS ranges, while CEO David Shaffer's successor takes over May 22, 2025.
Q4 fiscal 2025 net sales $974.8 million, up 7.0%; GAAP diluted EPS $2.41 vs. $1.48 a year earlier
Adjusted diluted EPS $2.97 vs. guidance of $2.75 to $2.85 given February 5, 2025
Q1 fiscal 2026 outlook: net sales $830 million to $870 million; adjusted diluted EPS $2.03 to $2.13; full-year guidance paused
Shawn O'Connell becomes President and CEO May 22, 2025; quarterly dividend $0.24 per share payable June 27, 2025 to holders of record June 13, 2025
LiveRamp reported fourth-quarter fiscal 2025 revenue of $189 million, up 10%, and a GAAP operating loss of $12 million, narrower than $14 million a year earlier. Its fiscal 2026 guidance calls for revenue of $787 million to $817 million but a GAAP operating loss of $178 million to $182 million, compared with GAAP operating income of $5 million in fiscal 2025, so shareholders face mixed signals on growth versus profitability.
Q4 total revenue was $189 million, up 10%; GAAP operating loss was $12 million versus $14 million a year earlier.
Q4 GAAP diluted loss per share was $0.10, compared with $0.08 a year earlier.
Fiscal 2026 guidance: revenue of $787 million to $817 million, GAAP operating loss of $178 million to $182 million, and non-GAAP operating income of $85 million to $89 million.
A workforce restructuring of about 5% of full-time employees, announced March 6, drove $7.2 million of Q4 restructuring and related charges.
Merit Medical completed its merger with Biolife on May 20, 2025, paying about $120 million in cash on hand, and updated its 2025 guidance to include the business. Net sales guidance was raised to $1.480 billion to $1.501 billion from $1.470 billion to $1.490 billion, while the non-GAAP earnings per share range moved to $3.28 to $3.41 from $3.29 to $3.42. Management said the deal will be slightly dilutive to 2025 non-GAAP profitability.
Purchase price of about $120 million, subject to standard adjustments, paid with available cash; merger effective May 20, 2025
Biolife projected to contribute $10 million to $11 million of revenue from May 20 to December 31, 2025, after about $15 million in revenue for the twelve months ended December 31, 2024
2025 net sales guidance raised to $1.480 billion to $1.501 billion; non-GAAP EPS guidance $3.28 to $3.41 versus prior $3.29 to $3.42
About $7.2 million of non-cash and non-recurring transaction expenses excluded from non-GAAP projections; deal projected to be dilutive to 2025 GAAP net income and EPS
Brady Corporation reported fiscal 2025 third-quarter results for the period ended April 30, 2025, with sales up 11.4% to $382.6 million, helped by acquisitions, while organic sales grew 1.6%. The company narrowed its full-year adjusted diluted EPS guidance to $4.48 to $4.63 from $4.45 to $4.70, and lowered its GAAP EPS guidance to $3.95 to $4.10 from $3.99 to $4.24, so shareholders get a record adjusted quarter alongside a lower GAAP outlook.
Q3 diluted EPS rose 3.8% to $1.09; adjusted diluted EPS rose 11.9% to a record $1.22
Sales of $382.6 million included 10.5% growth from acquisitions and 1.6% organic growth; Europe & Australia organic sales fell 5.4%
Full-year adjusted EPS guidance tightened to $4.48 to $4.63; GAAP EPS guidance lowered to $3.95 to $4.10
Returned $44.5 million to shareholders in the quarter through dividends and share repurchases
Take-Two Interactive reported fourth-quarter fiscal 2025 GAAP net revenue up 13% to $1.58 billion, but a GAAP net loss of $3.73 billion, or $21.08 per share, driven by a $3.55 billion goodwill impairment. For the full fiscal year, net revenue rose 5% to $5.63 billion while the net loss widened to $4.48 billion. The initial fiscal 2026 Net Bookings outlook is $5.9 to $6.0 billion, and the company expects a GAAP net loss per share of $(2.79) to $(2.45).
Q4 net revenue rose 13% to $1.58 billion from $1.40 billion; Net Bookings grew 17% to $1.58 billion
Q4 GAAP net loss was $3.73 billion ($21.08 per share), versus $2.90 billion ($17.02 per share) a year earlier
Full-year GAAP net loss was $4.48 billion ($25.58 per share), versus $3.74 billion ($22.01 per share); goodwill impairment was $3.55 billion
Fiscal 2026 outlook: Net Bookings of $5.9 to $6.0 billion and GAAP total net revenue of $5,950 to $6,050 million
DICK'S Sporting Goods agreed to acquire Foot Locker in a deal implying an equity value of about $2.4 billion and an enterprise value of about $2.5 billion, expected to close in the second half of 2025. The same day, DICK'S reported preliminary first-quarter 2025 results, with comparable sales up 4.5% and GAAP diluted EPS of $3.24, which the filing says remain subject to revision.
Foot Locker shareholders can elect $24.00 in cash or 0.1168 DICK'S shares for each Foot Locker share, with no minimum or maximum on either form of consideration.
DICK'S intends to finance the acquisition through cash-on-hand and new debt; Goldman Sachs provided fully committed bridge financing.
Preliminary Q1 2025 (quarter ended May 3, 2025): comparable sales growth of 4.5%; GAAP EPS $3.24, non-GAAP EPS $3.37 excluding $0.13 of investment losses.
The deal requires Foot Locker shareholder approval and regulatory approvals; the full Q1 results are scheduled for May 28, 2025.
FirstCash's subsidiary Chess Bidco agreed with H&T Group's board on a recommended all-cash acquisition of H&T, the UK's largest pawnbroker with 285 stores. The total equity value is approximately £297 million or $394 million, and the deal is expected to close in the second half of 2025, subject to H&T shareholder and UK regulatory approvals. The acquisition is financed partly by borrowing under FirstCash's existing revolving credit facility, and related amendments raise the leverage limit and restrict share repurchases.
Shareholders of H&T would receive 650 pence in cash per share plus a final dividend of 11 pence payable June 27, 2025, for 661 pence in total.
Total equity value is approximately £297 million or $394 million, based on the exchange rate as of May 13, 2025.
A £299 million bridge credit agreement with Jefferies Finance serves as a backstop; the credit facility leverage ratio limit rises to 3.75 to 1.00 for quarters ending through December 31, 2025.
Share repurchases would be limited to 0% of prior quarter consolidated net income if the leverage ratio is 3.50 to 1.00 or higher in any 2025 or 2026 fiscal quarter.
Acadia Healthcare reported first-quarter 2025 revenue of $770.5 million, up slightly from $768.1 million a year earlier, but net income attributable to the company fell to $8.4 million, or $0.09 per diluted share, from $76.4 million, or $0.83. The company affirmed its full-year 2025 guidance, which includes $2.50 to $2.80 in adjusted earnings per diluted share.
Revenue was $770.5 million versus $768.1 million in Q1 2024, a 0.3% increase.
Net income attributable to Acadia was $8.4 million ($0.09 per diluted share), down from $76.4 million ($0.83) a year earlier.
Adjusted EBITDA was $134.2 million versus $173.9 million, and transaction, legal and other costs were $31.1 million, including $31.0 million of government investigation costs.
Full-year 2025 guidance was affirmed, including revenue of $3.3 to $3.4 billion and adjusted EBITDA of $675 to $725 million.
Topgolf Callaway Brands reported first-quarter 2025 net revenues of $1,092.3 million, down 4.5% from a year earlier, and GAAP net income of $2.1 million, or $0.01 per diluted share, versus $6.5 million a year earlier. The company kept its full-year consolidated revenue and Adjusted EBITDA guidance but lowered its Topgolf revenue outlook because of a softer consumer environment, and the guidance remains subject to the pending sale of Jack Wolfskin.
Q1 2025 net revenues were $1,092.3 million, down 4.5%; GAAP net income was $2.1 million, or $0.01 per diluted share, versus $0.04 a year earlier.
Non-GAAP diluted EPS was $0.11 versus $0.08, and Adjusted EBITDA rose 4.0% to $167.3 million.
Full-year consolidated net revenue ($4.000 billion to $4.185 billion) and Adjusted EBITDA ($415 million to $505 million) guidance was maintained, while Topgolf revenue guidance was lowered to $1.680 billion to $1.790 billion from $1.725 bil
Q2 2025 outlook calls for consolidated net revenues of $1.075 billion to $1.115 billion and Adjusted EBITDA of $139 million to $159 million.
ZoomInfo reported first quarter 2025 GAAP revenue of $305.7 million, down 1% from a year earlier, while GAAP operating income rose to $50.3 million from $43.0 million and diluted EPS was $0.08 versus $0.04. The company raised the low end of its full-year 2025 GAAP revenue guidance to $1.195 billion-$1.205 billion from $1.185 billion-$1.205 billion, and its adjusted EPS guidance to $0.96-$0.98 from $0.95-$0.97. Shareholders also learn that the stock will begin trading under the symbol GTM on May 13, 2025.
GAAP revenue of $305.7 million, down 1% year over year; adjusted operating income of $100.9 million, down 15%
GAAP net income of $26.8 million, or $0.08 per diluted share, versus $15.1 million, or $0.04, a year earlier
Full-year 2025 GAAP revenue guidance of $1.195 billion-$1.205 billion, with the prior range at $1.185 billion-$1.205 billion
Common stock to trade on Nasdaq as GTM before market open on May 13, 2025, replacing the ZI symbol
RadNet reported first-quarter 2025 revenue of $471.4 million, up 9.2%, but Adjusted EBITDA fell 20.6% to $46.4 million and the company posted a net loss attributable to RadNet of $37.9 million, compared with a $2.8 million loss a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance ranges, citing the Southern California wildfires and severe winter weather that it said reduced first-quarter revenue by about $22 million.
Total Company revenue rose to $471.4 million from $431.7 million; Adjusted EBITDA fell to $46.4 million from $58.5 million.
Net loss per share was $(0.51) versus $(0.04) a year earlier; adjusted diluted loss per share was $(0.35) versus adjusted earnings of $0.07.
Imaging Center revenue guidance was raised to $1,835 million to $1,885 million from $1,825 million to $1,875 million; Adjusted EBITDA guidance was raised to $268 million to $276 million from $265 million to $273 million.
RadNet signed a definitive agreement on April 15, 2025 to acquire iCAD, Inc., subject to customary closing conditions.
Chewy said Chief Financial Officer David Reeder will leave the company to become a chief executive officer in the semiconductor industry, with his departure date still to be determined. The company also reaffirmed its first quarter fiscal 2025 guidance, and CEO Sumit Singh said the long-term plan remains intact.
Reeder notified Chewy on May 7, 2025 that he will resign as CFO and principal financial officer.
Reeder will remain CFO through the company's next earnings announcement in June, and the company is searching for a successor.
Chewy reaffirmed its previously announced first quarter fiscal 2025 guidance in a May 12, 2025 press release.
The filing states Reeder's resignation was not the result of any disagreement with the company on operations, policies, financial disclosures, or accounting matters.
Fortrea reported first-quarter 2025 revenue of $651.3 million, down from $662.1 million a year earlier, and a GAAP net loss of $562.9 million that includes a non-cash goodwill impairment charge of $488.8 million. Adjusted EBITDA rose to $30.3 million from $27.1 million, and the company reiterated its full-year 2025 guidance. Chairman and CEO Thomas Pike will step down on May 13, 2025, and Lead Independent Director Peter M. Neupert will serve as interim CEO and Board Chair.
Revenue was $651.3 million in the quarter, compared with $662.1 million in the first quarter of 2024.
GAAP net loss was $562.9 million, or $6.25 per diluted share, including the $488.8 million goodwill impairment; adjusted EPS was $0.02 versus $(0.05) a year earlier.
Adjusted EBITDA was $30.3 million, compared with $27.1 million in the first quarter of 2024.
Full-year 2025 guidance was reiterated at revenue of $2.45 billion to $2.55 billion and adjusted EBITDA of $170 million to $200 million; Peter M. Neupert becomes interim CEO on May 13, 2025.
Sally Beauty reported fiscal second-quarter results for the period ended March 31, 2025, with net sales down 2.8% to $883.1 million and comparable sales down 1.3%. GAAP diluted EPS rose to $0.38 from $0.27, and adjusted diluted EPS rose 20% to $0.42, while the company updated its full-year fiscal 2025 guidance and extended its share repurchase program to September 30, 2029.
Net sales of $883.1 million, down 2.8%; comparable sales down 1.3%, which the company attributed to weather, an unusually harsh flu season and macro uncertainty
GAAP diluted EPS of $0.38 versus $0.27 a year earlier; adjusted diluted EPS of $0.42 versus $0.35, a 20% increase
Full-year fiscal 2025 guidance: comparable sales flat to down 1%; adjusted operating margin of 8.0% to 8.5%
Board approved extending the share repurchase program to September 30, 2029, with $501.1 million remaining under the authorization
Koppers reported first-quarter 2025 sales of $456.5 million, down from $497.6 million, and a net loss attributable to Koppers of $13.9 million, compared with net income of $13.0 million a year earlier. The results include a $29.0 million loss on pension settlement and $20.0 million of impairment, restructuring and plant closure costs. The company lowered its 2025 sales forecast to $2.0 billion to $2.2 billion from $2.17 billion but kept its adjusted EBITDA goal of approximately $280 million and adjusted EPS goal of $4.75.
Adjusted EPS was $0.71 versus $0.62 a year earlier, while diluted EPS was $(0.68) versus $0.59
2025 sales forecast cut to $2.0 billion to $2.2 billion from $2.17 billion; adjusted EBITDA and adjusted EPS goals maintained
At the May 8, 2025 annual meeting, shareholders approved the amended 2020 Long Term Incentive Plan with 12,093,826 votes for and 5,231,663 against
Post Holdings reported fiscal second-quarter 2025 results for the period ended March 31, 2025. Net sales fell 2.3% to $1,952.1 million and diluted earnings per share fell to $1.03 from $1.48, while Adjusted EBITDA rose 0.4% to $346.5 million. The company raised its fiscal 2025 Adjusted EBITDA guidance to $1,430-$1,470 million, so shareholders get weaker reported sales and profit alongside a higher profit outlook.
Q2 net sales were $1,952.1 million, down 2.3% from $1,999.0 million a year earlier
Net earnings were $62.6 million, down 35.6%; diluted EPS was $1.03 versus $1.48
Adjusted EBITDA was $346.5 million, up 0.4% from $345.2 million
Fiscal 2025 Adjusted EBITDA guidance raised to $1,430-$1,470 million from $1,420-$1,460 million
American Healthcare REIT reported first quarter 2025 total revenues of $540.6 million, up from $499.5 million a year earlier, and raised its full-year 2025 guidance. GAAP net loss attributable to controlling interest widened to $6.8 million, or $(0.04) per diluted share, from $3.9 million a year earlier, mainly due to a $21.7 million impairment of a real estate investment. Shareholders get higher expected 2025 normalized FFO, but a larger GAAP loss in the quarter.
Total revenues were $540.6 million for the quarter ended March 31, 2025, compared with $499.5 million for the same period in 2024.
Normalized FFO attributable to common stockholders was $0.38 per diluted share, up from $0.30 a year earlier.
Full-year 2025 normalized FFO guidance was raised to $1.58 to $1.64 per diluted share from $1.56 to $1.60; total portfolio same-store NOI growth guidance rose to 9.0% to 13.0% from 7.0% to 10.0%.
Net loss attributable to controlling interest was $(6.8) million, compared with $(3.9) million a year earlier, after a $21.7 million impairment of a real estate investment.
Globus Medical reported first-quarter 2025 net sales of $598.1 million, down 1.4% from a year earlier, while GAAP net income rose to $75.5 million from a loss of $7.1 million. The company cut its full-year 2025 non-GAAP diluted EPS guidance to $3.00 to $3.30 from $3.10 to $3.40, but reaffirmed its full-year revenue guidance of $2.80 to $2.90 billion. Shareholders get a mixed picture: profit improved, but sales declined and the earnings outlook was lowered.
Net sales were $598.1 million, down 1.4% (down 0.8% on a constant currency basis); U.S. sales rose 0.2% while international sales fell 7.7%.
GAAP diluted EPS was $0.54, compared with a loss of $0.05 a year earlier; non-GAAP diluted EPS was $0.68, up from $0.63.
Full-year 2025 non-GAAP diluted EPS guidance was lowered to $3.00 to $3.30 from $3.10 to $3.40; revenue guidance of $2.80 to $2.90 billion was reaffirmed.
The company paid off the remaining $450 million of debt assumed from the NuVasive merger and reported free cash flow of $141.2 million.
Coinbase reported first-quarter 2025 total revenue of $2.0 billion, down 10% from the prior quarter, and net income of $66 million, with results weighed down by $597 million in pre-tax losses on its crypto investment portfolio. The letter also announced an agreement to acquire Deribit for approximately $2.9 billion, paid in $700 million cash and 11 million shares, which shareholders should weigh against the lower quarterly profit.
Q1 total revenue was $2.0 billion, down 10% from Q4 2024; transaction revenue was $1.3 billion, down 19%
Net income was $66 million, compared with $1.29 billion in Q4 2024; Adjusted EBITDA was $930 million
Subscription and services revenue rose 9% to $698 million, driven mainly by stablecoin revenue
Agreement to acquire Sentillia B.V. (Deribit) for about $2.9 billion, expected to close by year-end, subject to regulatory approvals
HubSpot reported first-quarter 2025 revenue of $714.1 million, up 16% from a year earlier, while its GAAP net result swung to a $21.8 million loss from $5.9 million of net income. The company also issued revenue and non-GAAP profit guidance for the second quarter and full year, and its board authorized a $500.0 million share repurchase program.
Q1 2025 total revenue $714.1 million, up 16% as reported; GAAP net loss $21.8 million ($0.42 per share) versus net income of $5.9 million ($0.12 per share) in Q1 2024
Non-GAAP diluted net income per share $1.78, compared with $1.68 in Q1 2024
Guidance: Q2 2025 revenue $738.0 million to $740.0 million; full-year 2025 revenue $3.036 billion to $3.044 billion and non-GAAP diluted EPS $9.29 to $9.37
Board authorized up to $500.0 million in share repurchases on May 6, 2025 over up to 12 months; Brian Halligan resigned as Executive Chairperson effective May 8, 2025 and Lorrie Harrington became Chairperson
Solventum reported first-quarter 2025 sales up 2.6% to $2.1 billion, with organic sales up 4.3%. Profit fell sharply: net income was $137 million versus $237 million a year earlier, and GAAP diluted EPS was $0.78 versus $1.37. The company raised its full-year 2025 organic sales growth outlook to +1.5% to +2.5% but left its adjusted EPS and free cash flow guidance unchanged.
Net sales rose 2.6% to $2.1 billion; organic sales rose 4.3% for the quarter.
GAAP diluted EPS was $0.78 versus $1.37; adjusted diluted EPS was $1.34 versus $2.08.
Free cash flow was negative $80 million versus $340 million a year earlier.
Full-year organic sales growth outlook raised to +1.5% to +2.5% from +1.0% to +2.0%; adjusted EPS guidance of $5.45 to $5.65 unchanged.
Fox Factory reported first-quarter fiscal 2025 net sales of $355 million, up 6.5% from a year earlier, but a $262.1 million goodwill impairment drove a net loss attributable to stockholders of $259.7 million, or $6.23 per diluted share. Adjusted earnings per diluted share fell to $0.23 from $0.29, and the company reaffirmed its full-year 2025 guidance while giving a second-quarter outlook.
Net sales rose $22 million, or 6.5%, to $355.0 million; the company cited tariff-related uncertainty and challenging end-market demand.
The goodwill impairment followed adverse U.S. tariff policy changes and a sustained decline in the stock price; goodwill fell to $377.2 million from $639.5 million.
Second-quarter guidance calls for net sales of $340 million to $360 million and adjusted earnings per diluted share of $0.32 to $0.62.
For fiscal 2025, the company reaffirmed net sales of $1.385 billion to $1.485 billion and adjusted earnings per diluted share of $1.60 to $2.60.
ScanSource reported fiscal third-quarter 2025 net sales of $704.8 million, down 6.3% year over year, while GAAP diluted EPS rose to $0.74 from $0.50. The company replaced its fiscal 2025 outlook, now expecting net sales of approximately $3 billion and adjusted EBITDA of $140 million to $145 million, and announced a new $200 million share repurchase authorization.
Q3 net sales were $704.8 million, down 6.3%; GAAP net income was $17.4 million, or $0.74 per diluted share, versus $0.50 a year earlier
Non-GAAP diluted EPS was $0.86, up 24.6%; adjusted EBITDA rose 5.9% to $35.1 million
FY25 outlook: net sales of approximately $3 billion (prior $3.1 billion to $3.5 billion); adjusted EBITDA of $140 million to $145 million (prior $140 million to $160 million); free cash flow at least $70 million, unchanged
Board approved a new $200 million buyback; about $42 million remained under the existing authorization as of March 31, 2025
Choice Hotels reported first-quarter 2025 net income of $44.5 million, up 44% from a year earlier, with diluted EPS of $0.94 versus $0.62. The company also lowered its full-year 2025 outlook, including net income guidance of $275 million to $290 million, down from $288 million to $300 million, and domestic RevPAR growth of -1% to 1%, down from 1% to 2%.
Q1 2025 total revenues were $333 million, compared with $332 million in Q1 2024.
Adjusted diluted EPS was $1.34, up 5% from $1.28, which the company called a first-quarter record.
Full-year 2025 adjusted diluted EPS guidance is $6.90 to $7.22, down from $6.98 to $7.24.
Management cited a more moderate domestic RevPAR growth expectation amid a changing macro backdrop.
Vericel reported first-quarter 2025 total revenue of $52.6 million, up from $51.3 million a year earlier, but its net loss widened to $11.2 million, or $0.23 per diluted share, from $3.9 million, or $0.08 per share. The company raised its full-year profitability guidance to a 74% gross margin and 26% adjusted EBITDA margin while reaffirming full-year revenue growth of 20% to 23%.
Q1 2025 total revenue of $52.6 million versus $51.3 million in Q1 2024; MACI net revenue of $46.3 million
Net loss of $11.2 million, or $0.23 per diluted share, versus a net loss of $3.9 million, or $0.08 per share, a year earlier
Full-year profitability guidance raised to 74% gross margin and 26% adjusted EBITDA margin
Second-quarter total revenue growth expected to be 22% to 25%; full-year revenue growth guidance of 20% to 23% reaffirmed
Maplebear Inc. (Instacart) said CEO Fidji Simo notified the company on May 7, 2025, of her intent to resign as CEO to pursue another opportunity, with the resignation date still to be determined. She will remain Board Chair, and the company says a new CEO will be announced soon. The company also reaffirmed its second quarter and fiscal 2025 financial outlook given on May 1, 2025.
CEO Fidji Simo notified the company on May 7, 2025, of her intent to resign as CEO.
The date of her resignation as CEO has not yet been determined.
Simo will continue as Chair of the Board of Directors.
The company reaffirmed its second quarter and fiscal 2025 outlook first given on its May 1, 2025 earnings call.
Viatris reported first quarter 2025 total revenues of $3.3 billion, down 11% from a year earlier, and a U.S. GAAP net loss of $3.0 billion, driven by a non-cash goodwill impairment charge of $2.9 billion. Adjusted EPS was $0.50, down 25%, and the company reaffirmed its 2025 outlook, including adjusted EPS guidance of $2.16 to $2.30. The filing also says the company has returned more than $450 million to shareholders year to date.
Total revenues $3.3 billion (down 11% reported; down 2% divestiture-adjusted operational basis); Indore Impact estimated at approximately $140 million in the quarter
U.S. GAAP net loss $(3.0) billion, or $(2.55) per share, versus net earnings of $114 million, or $0.09 per share, a year earlier
Adjusted EPS $0.50 versus $0.67 a year earlier; adjusted EBITDA $923.5 million, down 23%
2025 guidance reaffirmed; share repurchases of $500 million to $650 million expected in 2025
NetScout reported fourth-quarter fiscal 2025 revenue of $205.0 million, up from $203.4 million a year earlier, and GAAP net income of $18.6 million. For the full year, revenue fell to $822.7 million from $829.5 million, and the company posted a GAAP net loss of $366.9 million that includes $427.0 million in goodwill charges. Its CFO and COO are retiring effective May 31, 2025, with named successors starting June 1, 2025.
Q4 fiscal 2025 revenue was $205.0 million versus $203.4 million a year earlier; GAAP net income was $18.6 million, or $0.25 per diluted share, compared with a net loss of $32.4 million.
Fiscal 2025 revenue was $822.7 million versus $829.5 million; GAAP net loss was $366.9 million, or $(5.12) per diluted share, including goodwill charges of $427.0 million.
Fiscal 2026 outlook calls for revenue of $825 million to $865 million and GAAP diluted EPS of $1.07 to $1.22.
CFO Jean Bua and COO Michael Szabados step down effective May 31, 2025; Anthony Piazza becomes CFO and Sanjay Munshi becomes COO effective June 1, 2025.
Dave Inc. reported first quarter 2025 results on May 8, 2025, with revenue up 47% to $108.0 million and Adjusted EBITDA up 235% to $44.2 million. GAAP net income fell to $28.8 million from $34.2 million, a year-earlier period that included a $33.4 million gain on extinguishment of convertible debt. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance and authorized a $50 million share repurchase program.
Q1 2025 GAAP operating revenues of $108.0 million, up from $73.6 million in Q1 2024
GAAP net income of $28.8 million, down from $34.2 million; the prior-year period included a $33.4 million gain on extinguishment of convertible debt
Adjusted EBITDA of $44.2 million, up 235% from $13.2 million a year earlier
2025 revenue guidance raised to $460-$475 million from $415-$435 million; Adjusted EBITDA guidance raised to $155-$165 million from $110-$120 million
N-able reported first-quarter 2025 revenue of $118.2 million, up 3.9% year over year, and beat the high end of its first-quarter revenue and adjusted EBITDA guidance. It raised the midpoint of its full-year 2025 revenue outlook to $494.5 million from $489.5 million, but swung to a GAAP net loss of $7.2 million, or $(0.04) per diluted share, from net income of $7.5 million a year earlier.
Q1 2025 total revenue $118.2 million, up 3.9% year over year; GAAP net loss $7.2 million versus net income of $7.5 million in Q1 2024
Adjusted EBITDA $31.6 million, a 26.8% margin; non-GAAP net income $15.6 million, or $0.08 per diluted share
Full-year 2025 revenue midpoint raised to $494.5 million from $489.5 million; range $492 million to $497 million
Board approved a share repurchase program of up to $75 million of common stock
Crocs reported first-quarter 2025 revenue of $937 million, roughly flat from a year earlier, and GAAP diluted earnings per share of $2.83, up from $2.50. The company withdrew its full-year 2025 financial outlook, citing macroeconomic uncertainty from global trade policies, so shareholders no longer have company guidance for the year.
Q1 2025 revenue was $937 million, down 0.1% as reported and up 1.4% on a constant currency basis.
GAAP diluted EPS was $2.83 versus $2.50; adjusted diluted EPS was $3.00, approximately flat.
The full-year 2025 outlook provided on February 13, 2025 was withdrawn, with no replacement outlook given.
Crocs repurchased about 0.6 million shares for $61 million in the quarter, with about $1.3 billion of authorization remaining.
Valvoline reported fiscal second-quarter sales of $403 million, up 4%, while reported earnings per diluted share fell 9% to $0.30 and income from continuing operations fell 12% to $38 million. The company reiterated its fiscal 2025 guidance and said it named J. Kevin Willis as Chief Financial Officer, effective May 19, 2025, which shareholders may watch as the finance leadership changes.
Net revenues of $403.2 million rose 4% (11% excluding the impact of refranchising); reported EPS of $0.30 fell 9%
Adjusted EPS of $0.34 decreased 8%; adjusted EBITDA of $104 million declined 1%
Company reiterated fiscal 2025 guidance, including a target of 160 to 185 new store additions
J. Kevin Willis to become CFO effective May 19, 2025, with a base salary of $650,000; he succeeds Mary Meixelsperger, who is retiring
Peloton reported fiscal third-quarter 2025 results for the quarter ended March 31, 2025. Total revenue fell 13% year-over-year to $624.0 million, while the GAAP net loss narrowed to $47.7 million from $167.3 million a year earlier and Adjusted EBITDA rose to $89.4 million. The company raised its full-year FY25 Adjusted EBITDA guidance to $330 million to $350 million and its Total Revenue guidance to $2.455 billion to $2.470 billion.
Total revenue was $624.0 million, down 13% year-over-year, with Connected Fitness Products Revenue down 27% to $205.5 million.
GAAP net loss was $47.7 million, compared with $167.3 million in the same quarter last year.
Adjusted EBITDA was $89.4 million, and the company reported $94.7 million of Free Cash Flow in the quarter.
FY25 guidance: Adjusted EBITDA raised to $330 million to $350 million; Total Revenue raised to $2.455 billion to $2.470 billion; Total Gross Margin held at 50.0%.
Somnigroup reported first quarter 2025 net sales of $1,604.7 million, up 34.9%, driven largely by the February 5, 2025 Mattress Firm acquisition. The company swung to a net loss of $33.1 million, or $0.17 per diluted share, from net income of $76.3 million, or $0.43 per share, a year earlier, and revised its full-year 2025 adjusted EPS expectations to a range of $2.30 to $2.65.
Q1 net sales rose 34.9% to $1,604.7 million, including $593.7 million from Mattress Firm for the February 5 to March 31 stub period.
Net loss was $33.1 million (loss of $0.17 per diluted share) versus net income of $76.3 million ($0.43 per share) in Q1 2024; operating income fell to $13.2 million from $131.5 million.
Adjusted EPS was $0.49 versus $0.50 a year earlier; the company revised its full-year 2025 adjusted EPS range to $2.30 to $2.65.
Board declared a quarterly cash dividend of $0.15 per share, payable June 5, 2025, to holders of record on May 22, 2025.
Enovis reported first-quarter 2025 net sales of $559 million, up 8% on a reported basis, and a net loss from continuing operations of $56 million, or $0.98 per share, compared with a loss of $1.32 per share a year earlier. The company raised its 2025 revenue outlook to $2.22-2.25 billion but cut its adjusted EBITDA forecast to $385-395 million from $405-415 million and its adjusted EPS forecast to $2.95-3.10 from $3.10-3.25, with the EBITDA outlook including $20 million of tariff-related impact.
Net sales of $559 million grew 8% on a reported basis and 9% on a comparable basis; Reconstructive sales rose 11%.
Adjusted EBITDA was $99 million, or 17.7% of sales, up 160 basis points from the prior-year quarter.
Adjusted EPS was $0.81 versus $0.50 a year earlier; GAAP net loss per share narrowed to $0.98 from $1.32.
2025 revenue outlook raised to $2.22-2.25 billion; adjusted EBITDA outlook cut to $385-395 million and adjusted EPS outlook cut to $2.95-3.10.
Wolverine World Wide reported first-quarter 2025 revenue of $412.3 million, up 4.4% from $394.9 million a year earlier, and diluted earnings per share of $0.13 versus a loss of $0.19. The company withdrew its full-year 2025 guidance, citing uncertainty around tariffs and macroeconomic conditions, while forecasting second-quarter revenue of $440 million to $450 million.
Q1 2025 diluted EPS of $0.13 versus a loss of $0.19 in Q1 2024; adjusted diluted EPS of $0.18 versus $0.05
Q1 2025 revenue of $412.3 million, up 4.4%; gross margin 47.3% versus 45.9%
Full-year 2025 outlook withdrawn; prior guidance issued February 19, 2025 is withdrawn
Second-quarter 2025 revenue expected at $440 million to $450 million; diluted EPS $0.17 to $0.22
Lincoln National reported a first-quarter 2025 net loss available to common stockholders of $756 million, or $4.41 per diluted share, compared with net income of $1,191 million a year earlier. The company said the loss mainly reflected changes in market risk benefits from lower interest rates and equity markets, while adjusted operating income rose to $280 million, or $1.60 per diluted share, from $210 million, or $1.22.
Net loss available to common stockholders was $756 million, or $4.41 per diluted share, versus net income of $1,191 million, or $6.93 per diluted share, in Q1 2024.
Adjusted operating income available to common stockholders was $280 million, or $1.60 per diluted share, up from $210 million, or $1.22.
Group Protection operating income rose 26% to $101 million, with an operating margin of 7.4%.
A minority investment from Bain Capital is expected to close in the second half of 2025.
Haemonetics reported fourth-quarter fiscal 2025 revenue of $330.6 million, down 3.7% from a year earlier, while GAAP earnings per diluted share rose to $1.17 from $0.40 and adjusted EPS rose 37.8% to $1.24. The company also issued fiscal 2026 guidance, including adjusted EPS of $4.70 to $5.00, and approved a market and regional alignment initiative expected to bring about $20 million in restructuring charges and about $30 million in annualized savings.
Q4 fiscal 2025 revenue $330.6 million, down 3.7%; organic revenue down 0.2%, with Plasma down 9.1% and Blood Center down 22.2%
Q4 GAAP EPS $1.17 vs $0.40; adjusted EPS $1.24, up 37.8%
Fiscal 2026 guidance: adjusted EPS $4.70 to $5.00, adjusted operating margin 26% to 27%, free cash flow $160 million to $200 million
Alignment initiative: about $20 million in charges, mostly cash, through fiscal 2027; about $30 million annualized savings once complete
EPAM reported first-quarter 2025 revenue of $1.302 billion, up 11.7% from a year earlier, but GAAP diluted EPS fell 35.0% to $1.28 and non-GAAP diluted EPS fell 2.0% to $2.41. The company raised its full-year 2025 revenue growth outlook to 11.5% to 14.5%, and CEO Arkadiy Dobkin will become Executive Chairman on September 1, 2025, with Balazs Fejes succeeding him as CEO and President. Organic constant currency revenue growth was 1.4% in the quarter, so most of the reported growth came from acquisitions and currency effects.
Q1 2025 revenue was $1.302 billion, up 11.7%; organic constant currency growth was 1.4%
Q1 GAAP diluted EPS was $1.28, down 35.0%; non-GAAP diluted EPS was $2.41, down 2.0%
Full-year 2025 revenue growth outlook raised to 11.5% to 14.5%; GAAP diluted EPS outlook is $6.78 to $7.03
Balazs Fejes becomes CEO and President effective September 1, 2025, succeeding Arkadiy Dobkin, who becomes Executive Chairman
Kinetik Holdings reported first quarter 2025 results, with total operating revenues of $443.3 million, up from $341.4 million a year earlier, and Adjusted EBITDA of $250.0 million, up from $233.6 million. Net income fell to $19.3 million from $35.4 million, and diluted earnings per share were $0.05 versus $0.12, while the company affirmed its 2025 Adjusted EBITDA guidance of $1.09 billion to $1.15 billion and raised its share repurchase authorization to $500 million.
Total operating revenues were $443.3 million, compared with $341.4 million in the first quarter of 2024.
Net income including noncontrolling interest was $19.3 million, versus $35.4 million; diluted EPS was $0.05, versus $0.12.
Adjusted EBITDA was $250.0 million, versus $233.6 million; the company said current commodity futures would reduce full-year Adjusted EBITDA by about $20 million.
The Board authorized an increase to the share repurchase program to $500 million and affirmed 2025 Adjusted EBITDA guidance of $1.09 billion to $1.15 billion.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.